Robert Kushner: The STEP trials were the phase three foundational clinical trials for Novo Nordisk that brought semaglutide to the market
Whilst mild, transient joint discomfort may not require urgent medical attention , certain features of joint pain warrant prompt evaluation by your GP or healthcare provider

If cholelithiasis is suspected, gallbladder diagnostic studies and appropriate clinical follow-up are indicated Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include: pain in your upper stomach (abdomen) fever yellowing of skin or eyes (jaundice) clay-colored stools Low Blood Sugar (Hypoglycemia) Your risk for getting low blood sugar may be higher if you use MOUNJARO with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin Signs and symptoms of low blood sugar may include: dizziness or light-headedness sweating confusion or drowsiness headache blurred vision slurred speech shakiness fast heartbeat anxiety, irritability, or mood changes hunger weakness feeling jittery Concomitant use with an insulin secretagogue (e.g., sulfonylurea) or insulin may increase the risk of hypoglycemia, including severe hypoglycemia The risk of hypoglycemia may be lowered by reducing the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin

The lightweight cream texture spreads smoothly and absorbs effortlessly, leaving the skin with a soft, hydrated finish no white cast, no greasiness, and no pilling under makeup
115-38, PMID 10548966